Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks

Headache

Volumn 45, Issue 2, 2005, Pages 137-143

  Wammes van Der Heijden, Elisabeth A ^a   Smidt, Martijn H ^b   Tijssen, Cees C ^b   Van 't Hoff, Annelies R ^c   Lenderink, Albert W ^d   Egberts, Antoine C G ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b CPRLab   (Netherlands)

^c GGD Midden Brabant   (Netherlands)

^d GGZ Midden Brabant   (Netherlands)

Author keywords

Acenocoumarol; Anticoagulation; Migraine; Migraine prophylaxis

Indexed keywords

ACENOCOUMAROL; PROPRANOLOL;

ADULT; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; COLD LIMB; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; EPISTAXIS; FATIGUE; FEMALE; HEMATOMA; HUMAN; MALE; MENSTRUATION DISORDER; MIGRAINE; NIGHTMARE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN TINGLING; SLEEP DISORDER; SYMPTOM; TREATMENT OUTCOME; WEIGHT GAIN;

ACENOCOUMAROL; ADULT; ANTICOAGULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIGRAINE DISORDERS; PROPRANOLOL; TREATMENT OUTCOME;

EID: 14644404326     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05028.x     Document Type: Article

References (22)

1. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia. 2001;21(6):630-636.
2. Thonnard-Neumann E. Migraine therapy with heparin: pathophysiologic basis. Headache. 1977;16(6):284-292.
3. Behnen HJ. [Migraine and marcumar]. Dtsch Med Wochenschr. 1979;104(1):32-33.
4. van Puijenbroek EP, Egberts JF, Trooster JF, Zomerdijk J. Reduction of migrainous headaches during the use of acenocoumarol. Headache. 1996;36(1):48.
5. Anderson G. Migrän och warfarinnatrium. Lakarttidningen. 1981;78(21):2147.
6. Fragoso YD. Reduction of migraine attacks during the use of warfarin. Headache. 1997;37(10):667-668.
7. Suresh CG, Neal D, Coupe MO. Warfarin treatment and migraine. Postgrad Med J. 1994;70(819):37-38.
8. Morales-Asin F, Iniguez C, Cornudella R, Mauri JA, Espada F, Mostacero EE. Patients with acenocoumarol treatment and migraine. Headache. 2000;40(1):45-47.
9. Rahimtoola H, Egberts AC, Buurma H, Tijssen CC, Leufkens HG. Reduction in the intensity of abortive migraine drug use during coumarin therapy. Headache. 2001;41(8):768-773.
10. Tfelt-Hansen P, Nielsen SL. Patient numbers needed in prophylactic migraine trials. Neuroepidemiology. 1987;6(4):214-219.
11. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med. 1993;153(13):1557-1562.
12. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost. 1996;76(1):12-16.
13. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20(9):765-786.
14. Cuadrado MJ, Khamashta MA, Hughes GR. Migraine and stroke in young women. Q J Med. 2000;93(5):317-318.
15. Cuadrado MJ, Khamashta MA, D'Cruz D, Hughes GR. Migraine in Hughes syndrome - heparin as a therapeutic trial? Q J Med. 2001;94(2):114-115.
16. Wammes-van der Heijden EA, Tijssen CC, van 't Hoff AR, Egberts ACG. A thromboembolic predisposition and the effect of anticoagulation on migraine. Headache. 2004;44(5):399-402.
17. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 2002;13(2):102-106.
18. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62:1399-1401.
19. Post MC, Thijs V, Herroelen L, Budts WIHL. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004;62:1439-1440.
20. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15(2):94-100.
21. Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia. 1998;18(1):27-32.
22. Schoedon G, Blau N, Schneemann M, Flury G, Schaffner A. Nitric oxide production depends on preceding tetrahydrobiopterin synthesis by endothelial cells: selective suppression of induced nitric oxide production by sepiapterin reductase inhibitors. Biochem Biophys Res Commun. 1994;199(2):504-510.